CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Open-market sale Director sold 7,324 shares at $16.16 ($118,349)
- 4 Open-market sale Director sold 45,539 shares at an average $16.45 ($749,002)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 19,565 shares at $15.14 ($296,269)
- 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
- 4 Gift Director gave 709 shares (gift)
- 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
- 4 Open-market sale President and CEO sold 70,000 shares at an average $15.15 ($1,060,701)
- 4 Open-market sale Chief Scientific Officer sold 30,000 shares at $16.28 ($488,298)
- 4 Open-market sale President and CEO sold 56,303 shares at $15.91 ($896,045)
- 4 Open-market sale Chief Financial Officer sold 12,823 shares at $15.55 ($199,335)
- 4 Open-market sale Chief Scientific Officer sold 27,165 shares at $15.71 ($426,803)
Page 8 of 21 · 414 filings